Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-17-047403
Filing Date
2017-09-11
Accepted
2017-09-11 12:29:01
Documents
3
Period of Report
2017-09-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A v474900_pre14a.htm PRE 14A 372914
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-17-047403.txt   374521
Mailing Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505
Business Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-51474 | Film No.: 171078531
SIC: 2834 Pharmaceutical Preparations